ETHZilla, formerly known as 180 Life Sciences, has announced a comprehensive rebranding and strategic pivot towards Ethereum adoption. The company will allocate $238 million to Ethereum as part of a new corporate treasury strategy designed to enhance shareholder value, with investment firm Electric Capital appointed to manage its on-chain yield program.
The rebranding signifies ETHZilla’s shift towards integrating Ethereum into its core financial strategy. This move aligns with Ethereum’s market resurgence, evidenced by its 13.37% market dominance and 72.26% price appreciation over the past 90 days. The cryptocurrency recently surpassed the $4500 price level for the first time since December 2021, reflecting significant market momentum.